Updated Jul 16, 2026
Harmon Cyrus has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $723K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-22 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 10.0K | $26.88 | $269K |
| 2026-01-17 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 3.5K | $29.12 | $102K |
| 2025-09-16 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 3.1K | $8.32 | $26K |
| 2025-09-16 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 1.9K | $8.08 | $15K |
| 2025-09-16 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 10.0K | $8.33 | $83K |
| 2025-09-16 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 10.0K | $8.04 | $80K |
| 2024-12-11 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 179 | $9.39 | $2K |
| 2024-12-11 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 8.0K | $8.66 | $69K |
| 2024-12-11 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 8.3K | $9.37 | $77K |
| 2024-12-11 | OLMA | Olema Pharmaceuticals, Inc. | A — Grant or award | 29.2K | $0.00 |
Harmon Cyrus is a corporate insider — currently tracked as Insider of Olema Pharmaceuticals, Inc. (OLMA). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 9 open-market sales ($723K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Harmon Cyrus profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.